CTNM

Contineum Therapeutics, Inc. Class A · NASDAQ

Sector Health Technology
Industry Biotechnology
Website -
Employees(FY) -
ISIN US21217B1008

Performance

-3.25%

1W

-0.32%

1M

+0.65%

3M

+0.65%

6M

+0.65%

YTD

+0.65%

1Y

Profile

-

Advanced Technical Analysis

Recent News & Updates

2024-05-16 04:05
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights(Businesswire)
2024-04-04 09:02
Contineum Therapeutics Announces Pricing of Initial Public Offering(Globenewswire)

Page 1 of 1

previousnext